Since the US Department of Health and Human Services announced a proposal to lower medicine prices, pharmaceutical stocks have plummeted. Some of the firms that have seen their stock prices tumble include Johnson & Johnson, AbbVie, Pfizer, and Eli Lilly and Company. At a compound annual growth rate (CAGR) of 1.8 percent, the global pharmaceutical market is expected to reach $1.25 trillion in 2021. The presence and continued development of vaccines and boosters is one of the drivers of the pharmaceutical sector’s sustained expansion.
Insider Monkey looks at the 10 best big pharma stocks to buy now. Moderna, Inc., a prominent pharmaceutical company, is waiting for FDA approval for its COVID-19 vaccine and booster. The corporation announced the signing of a $20 billion Advanced Purchase Agreements in its second-quarter financial report. The pharmaceutical company AstraZeneca PLC is situated in the United Kingdom. It is ranked ninth among the top ten major pharma stocks to purchase right now. In the second quarter, the company’s sales were $8.22 billion, which was $768.98 million higher than expected. Amgen Inc. is a California-based pharmaceutical company that rates eighth among the top ten big-pharma companies to purchase right now. Psoriasis, arthritis, osteoporosis, anemia, and cancer are among the conditions the company produces and sells drugs for. Gilead Sciences, Inc. is a biopharmaceutical business based in California that conducts research. Veklury, an injectable antiviral injection used to treat COVID-19, was also developed by the business. It is ranked seventh among the top ten major pharma stocks to purchase right now. Abbott Laboratories, a medical device, and pharmaceutical firm, is ranked sixth among the top ten major pharma companies to purchase right now. Irritable bowel syndrome, hypertension, migraine, vertigo, and hypothyroidism are all treated with generic medications sold by the company’s pharmaceutical business. For more details, click 10 Best Big Pharma Stocks To Buy Now.
Pixabay
